Hexagon Capital Partners’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-89
Closed -$12.4K 839
2025
Q1
$12.4K Sell
89
-109
-55% -$16.9K ﹤0.01% 912
2024
Q4
$30.7K Buy
198
+1
+0.5% +$169 0.01% 637
2024
Q3
$35.9K Buy
197
+122
+163% +$18.1K 0.01% 519
2024
Q2
$8.91K Buy
75
+23
+44% +$2.42K ﹤0.01% 901
2024
Q1
$5.58K Buy
52
+43
+478% +$4.28K ﹤0.01% 977
2023
Q4
$898 Buy
9
+3
+50% +$293 ﹤0.01% 1244
2023
Q3
$714 Sell
6
-21
-78% -$3.13K ﹤0.01% 1226
2023
Q2
$4.81K Sell
27
-8
-23% -$1.47K ﹤0.01% 910
2023
Q1
$5.77K Sell
35
-7
-17% -$1.2K ﹤0.01% 864
2022
Q4
$6.61K Sell
42
-19
-31% -$2.89K ﹤0.01% 841
2022
Q3
$9K Buy
61
+42
+221% +$6.99K ﹤0.01% 797
2022
Q2
$3K Buy
+19
New +$3.66K ﹤0.01% 902

Other funds holding ICUI

Hexagon Capital Partners's ICUI Position: Q2 2025 in Review

Hexagon Capital Partners sold out of ICU Medical (ICUI) in Q2 2025, closing a stake of 89 shares — an estimated $12.4K sold.

Hexagon Capital Partners first reported a position in ICUI in Q2 2022 and held it in 12 quarters. The position peaked at $35.9K in Q3 2024. 271 funds tracked by Wall St. Rank hold ICUI as of Q2 2025.

  • Hexagon Capital Partners reported no remaining ICU Medical position as of Q2 2025 after selling out during the quarter.
  • Hexagon Capital Partners sold 89 ICU Medical shares in Q2 2025, an estimated $12.4K.
  • Hexagon Capital Partners first reported a position in ICU Medical in Q2 2022 and held it in 12 quarters.
  • Hexagon Capital Partners's ICU Medical position peaked at $35.9K in Q3 2024.
  • 271 funds tracked by Wall St. Rank held ICU Medical as of Q2 2025.

Based on Hexagon Capital Partners's 13F filing for Q2 2025, filed 11 Aug 2025.